Progress of small molecule targeted therapy for acute myeloid leukemia

VernacularTitle:急性髓系白血病小分子靶向治疗研究进展
Author: Lin CHEN ¹ ; Xudong WEI
Author Information

1. 郑州大学附属肿瘤医院　河南省肿瘤医院血液科，郑州　450003
Keywords: Leukemia, myeloid, acute; Molecular targeted therapy; Allogeneic hematopoietic stem cell transplantation
From: Journal of Leukemia & Lymphoma 2023;32(2):82-85
CountryChina
Language:Chinese
Abstract: Acute myeloid leukemia (AML) is the most common subtype of acute leukemia in adults with significant heterogeneity. Among hematological malignancies, targeted therapy for AML comes relatively late. Although traditional chemotherapy is still an indispensable part of AML treatment, more and more small molecule targeted drugs have been used in recent years since 2017. This article reviews the progress of small molecule targeted drugs for AML at the 64th American Society of Hematology annual meeting.